Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2016 1
2017 1
2018 1
2020 1
2021 1
2022 1
2023 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial.
Lebrun-Frénay C, Siva A, Sormani MP, Landes-Chateau C, Mondot L, Bovis F, Vermersch P, Papeix C, Thouvenot E, Labauge P, Durand-Dubief F, Efendi H, Le Page E, Terzi M, Derache N, Bourre B, Hoepner R, Karabudak R, De Seze J, Ciron J, Clavelou P, Wiertlewski S, Turan OF, Yucear N, Cohen M, Azevedo C, Kantarci OH, Okuda DT, Pelletier D; TERIS Study Group. Lebrun-Frénay C, et al. JAMA Neurol. 2023 Oct 1;80(10):1080-1088. doi: 10.1001/jamaneurol.2023.2815. JAMA Neurol. 2023. PMID: 37603328 Free PMC article. Clinical Trial.
Patients With Severe Multiple Sclerosis Exhibit Functionally Altered CD8+ Regulatory T Cells.
Benallegue N, Nicol B, Lasselin J, Bézie S, Flippe L, Regue H, Vimond N, Remy S, Garcia A, Le Frère F, Anegon I, Laplaud D, Guillonneau C. Benallegue N, et al. Among authors: le frere f. Neurol Neuroimmunol Neuroinflamm. 2022 Oct 20;9(6):e200016. doi: 10.1212/NXI.0000000000200016. Print 2022 Nov. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 36266052 Free PMC article.
Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis.
Garcia A, Dugast E, Shah S, Morille J, Lebrun-Frenay C, Thouvenot E, De Sèze J, Le Page E, Vukusic S, Maurousset A, Berger E, Casez O, Labauge P, Ruet A, Raposo C, Bakdache F, Buffels R, Le Frère F, Nicot A, Wiertlewski S, Gourraud PA, Berthelot L, Laplaud D. Garcia A, et al. Among authors: le frere f. Neurol Neuroimmunol Neuroinflamm. 2023 Feb 21;10(3):e200091. doi: 10.1212/NXI.0000000000200091. Print 2023 May. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 36810163 Free PMC article.
SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosis.
Lejeune F, Chatton A, Laplaud DA, Le Page E, Wiertlewski S, Edan G, Kerbrat A, Veillard D, Hamonic S, Jousset N, Le Frère F, Ouallet JC, Brochet B, Ruet A, Foucher Y, Michel L. Lejeune F, et al. Among authors: le frere f. J Neurol. 2021 Feb;268(2):669-679. doi: 10.1007/s00415-020-10154-5. Epub 2020 Sep 9. J Neurol. 2021. PMID: 32902734
Neuropathologic, phenotypic and functional analyses of Mucosal Associated Invariant T cells in Multiple Sclerosis.
Salou M, Nicol B, Garcia A, Baron D, Michel L, Elong-Ngono A, Hulin P, Nedellec S, Jacq-Foucher M, Le Frère F, Jousset N, Bourreille A, Wiertlewski S, Soulillou JP, Brouard S, Nicot AB, Degauque N, Laplaud DA. Salou M, et al. Among authors: le frere f. Clin Immunol. 2016 May;166-167:1-11. doi: 10.1016/j.clim.2016.03.014. Epub 2016 Apr 2. Clin Immunol. 2016. PMID: 27050759
Increased risk of multiple sclerosis relapse after in vitro fertilisation.
Michel L, Foucher Y, Vukusic S, Confavreux C, de Sèze J, Brassat D, Clanet M, Clavelou P, Ouallet JC, Brochet B, Pelletier J, Labauge P, Lebrun C, Lepage E, Le Frere F, Jacq-Foucher M, Barriere P, Wiertlewski S, Laplaud DA; Club Francophone de la Sclérose En Plaques (CFSEP). Michel L, et al. Among authors: le frere f. J Neurol Neurosurg Psychiatry. 2012 Aug;83(8):796-802. doi: 10.1136/jnnp-2012-302235. Epub 2012 Jun 11. J Neurol Neurosurg Psychiatry. 2012. PMID: 22693287
An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8+ T cells involved in multiple sclerosis.
Nicol B, Salou M, Vogel I, Garcia A, Dugast E, Morille J, Kilens S, Charpentier E, Donnart A, Nedellec S, Jacq-Foucher M, Le Frère F, Wiertlewski S, Bourreille A, Brouard S, Michel L, David L, Gourraud PA, Degauque N, Nicot AB, Berthelot L, Laplaud DA. Nicol B, et al. Among authors: le frere f. J Autoimmun. 2018 Mar;88:61-74. doi: 10.1016/j.jaut.2017.10.005. Epub 2017 Oct 18. J Autoimmun. 2018. PMID: 29054368 Free article.